Direkt zum Inhalt
Merck

LC/MS Analysis of Bile Acids and Their Conjugates on Ascentis® Express C18

LC/MS Analysis of Bile Acids and Their Conjugates on Ascentis® Express C18 application for HPLC

Materialien

Analytische Säule

Produkt-Nr.
Beschreibung
Preisangaben

Ascentis® Express C18, 2,7 μm HPLC-Säule

2.7 μm particle size, L × I.D. 15 cm × 4.6 mm

Komponente der mobilen Phase

Produkt-Nr.
Beschreibung
Preisangaben

Ammoniumacetat

LiChropur, eluent additive for LC-MS

Standard

Produkt-Nr.
Beschreibung
Preisangaben

Taurocholsäure Natriumsalz Hydrat

BioXtra, ≥95% (HPLC)

Ursodesoxycholsäure

≥99%

Cholinsäure

from bovine and/or ovine, ≥98%

Lithocholsäure

≥95%

Glycocholsäure Hydrat

synthetic, ≥97% (HPLC)

CONDITIONS

sample/matrix

Plasma proteins were removed with addition of 900 μL of acetonitrile, containing deuterated internal standards, to 250 μL of human EDTA plasma. The mixture was vortexed, (centrifuged and the supermatant evaporated before being reconstituted in a 50:50 solution of methanol and water. 10 μL (corresponding to 8.57 μL of plasma) was injected into the HPLC.)

column

Ascentis Express C18, 15 cm x 4.6 mm I.D., 2.7 μm particles (53829-U)

mobile phase

[A]: Water (5 mM ammonium acetate and 0.012% formic acid); [B]: Methanol (5 mM ammonium acetate and 0.012% formic acid)

gradient

70 to 95% B in 10 minutes held 4 minutes

flow rate

0.6 mL/min

column temp.

40 °C

detector

ESI(-), MRM Mode

Beschreibung

Hinweis zur Analyse

A fast robust LC-MS/MS method was developed on a C18 Ascentis Express Fused-CoreR Particle Column allowing the 15 bile acid species to be measured individually rather than the alternative measurement of a total concentration by colourimetric kinetic enzyme assays.

Rechtliche Hinweise

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany